Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
Magnetite nanoparticles (MgNPs), have a unique property of superparamagnetism and reactive oxygen specimens (ROS) production, which can enhance the delivery and treatment efficiency of anti-cancer drugs. In this study, we have shown that in vitro enhanced effects of bare/surface modified MgNPs combined with docetaxel in comparison with docetaxel in prostate cancer cells via different mechanisms. In addition, effect of MgNPs on zyxin expression may be related with ROS production.
|